Mitochondrial Fission and Fusion in Alzheimer Disease
阿尔茨海默病中的线粒体裂变和融合
基本信息
- 批准号:7575733
- 负责人:
- 金额:$ 32.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenovirusesAffectAlzheimer&aposs DiseaseAreaAxonAxonal TransportBindingBrainBuffersCalciumCellsCessation of lifeChimeric ProteinsCognitive deficitsDefectDendritesDendritic SpinesDoseDynaminDynamin IEnergy SupplyEquilibriumEventFibroblastsFunctional disorderGene TransferGuanosine Triphosphate PhosphohydrolasesHippocampus (Brain)HumanIn VitroMeasuresMediatingMembrane PotentialsMicroscopicMitochondriaMitochondrial DNAModelingMorphologyMovementMusNeuritesNeuronal DysfunctionNeuronsOrganellesPathogenesisPatientsPeptide HydrolasesPhysiologicalPlayPresynaptic TerminalsProcessProductionProteinsRegulationRoleSiteSynapsesSynaptic TransmissionSynaptic plasticitySystemTeratomaTestingTg2576TimeToxic effectTransgenic MiceTretinoinVertebral columnbasecognitive functioncyclooxygenase 1environmental enrichment for laboratory animalsequilibration disorderhippocampal pyramidal neuronimprovedin vivoknock-downmitochondrial dysfunctionmutantoverexpressionpolarized cellpublic health relevancesynaptogenesis
项目摘要
DESCRIPTION (provided by applicant): Early changes in AD brain include loss of synapses. AB, considered to have a central role in the pathogenesis of AD, bind to dendritic spines and cause synaptic dysfunction. However, the mechanisms responsible for AB-induced synaptic dysfunction and spine loss are not firmly established. Notably, synaptic terminals have abundant mitochondria which play an indispensable role at these sites. Along this line, mitochondrial dysfunction is an early prominent feature of AD neurons. Mitochondria are dynamic organelles that undergo continual fission and fusion events which are regulated by a machinery involving large dynamin-related GTPase that exert opposing effects, e.g., dynamin-like protein 1 (DLP1) and Fis1 for fission, and mitofusins (Mfn1 and Mfn2C) and OPA1 for fusion. These mitochondria fission and fusion proteins control not only mitochondrial number and morphology but also mitochondrial distribution and function. Indeed, defects in the mitochondrial fission/fusion balance and thus, the morphology and distribution have the potential to cause localized energy and calcium imbalance, which is especially damaging to polarized cells such as neurons, resulting in cellular dysfunction and death. Our preliminary studies suggest that the normally strict regulation of mitochondria morphology and distribution is impaired in AD neurons and fibroblasts which may be caused by differential expression of mitochondrial fission/fusion proteins induced by AB. Our central hypothesis is that AB induces mitochondrial dysfunction and synaptic abnormalities via its toxic effect on mitochondrial fission/fusion. Four aims will be pursued: Aim1) ADDLs induce mitochondrial dysfunction and synaptic abnormalities via its toxic effect on mitochondrial fission/fusion in vitro; Aim2) To Explore the Mechanisms of ADDL-induced DLP1 Reduction; Aim3) mutant PS1 causes mitochondrial abnormalities and neuronal dysfunction at least in part through its interaction with DLP1 and impaired balance in mitochondrial fission/fusion; Aim 4) DLP1 reduction underlies mitochondrial abnormalities and synaptic loss in vivo. PUBLIC HEALTH RELEVANCE: AB-caused synaptic dysfunction and spine loss is an early change and the most robust correlate of AD- associated cognitive deficits, however the underlying mechanism is not firmly established. It is known that mitochondria play an indispensable role in synaptic terminals and the balance of mitochondrial fission/fusion is critical for mitochondrial distribution and function. Our preliminary studies suggest the potential involvement of an impaired balance of mitochondrial fission/fusion in the pathogenesis of AD, in this application, we propose to investigate whether AB cause synaptic dysfunction and mitochondrial abnormalities via its toxic effect on the balance of mitochondrial fission and fusion.
描述(由申请人提供):AD大脑的早期变化包括突触的丧失。 AB被认为在AD的发病机理中具有核心作用,与树突状刺结合并引起突触功能障碍。但是,尚未确定导致AB诱导的突触功能障碍和脊柱损失的机制。值得注意的是,突触末端具有丰富的线粒体,在这些位点起着必不可少的作用。沿着这条线,线粒体功能障碍是AD神经元的早期突出特征。线粒体是动态细胞器,经历了持续的裂变和融合事件,受涉及大型动力蛋白相关GTPase的机械调节,例如发挥相反效果,例如Dynampyin-like蛋白1(DLP1)和FIS1进行裂变,以及Mitofusins,以及Mitofusins(MFN1和MFN1和MFN1和MFN2C)和Opa1和Opa1。这些线粒体裂变和融合蛋白不仅控制线粒体数和形态,还可以控制线粒体分布和功能。实际上,线粒体裂变/融合平衡的缺陷,因此,形态和分布有可能引起局部能量和钙不平衡,这尤其损害了偏振细胞,例如神经元,从而导致细胞功能障碍和死亡。我们的初步研究表明,在AD神经元和成纤维细胞中,通常严格调节线粒体形态和分布,这可能是由于AB诱导的线粒体裂变/融合蛋白的差异表达引起的。我们的中心假设是,AB通过其对线粒体裂变/融合的毒性作用诱导线粒体功能障碍和突触异常。将追求四个目标:AIM1)ADDL通过其对线粒体裂变/体外线粒体融合的毒性作用而诱导线粒体功能障碍和突触异常; AIM2)探索ADDL诱导的DLP1减少的机制; AIM3)突变体PS1引起线粒体异常和神经元功能障碍至少部分通过与DLP1的相互作用和线粒体裂变/融合的平衡受损而受损; AIM 4)DLP1减少是线粒体异常和体内突触损失的基础。公共卫生相关性:AB引起的突触功能障碍和脊柱损失是早期的变化,并且是与认知缺陷的最牢固相关性的,但是基本机制并未牢固确定。众所周知,线粒体在突触末端起着必不可少的作用,线粒体裂变/融合的平衡对于线粒体分布和功能至关重要。我们的初步研究表明,线粒体裂变/融合在AD发病机理中的平衡受损的潜在参与,在本应用中,我们建议研究AB是否会通过其对线粒体裂变和融合平衡的毒性作用而引起突触的功能障碍和线粒体异常。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xiongwei Zhu其他文献
Xiongwei Zhu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xiongwei Zhu', 18)}}的其他基金
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
Mettl3 依赖性 RNA m6A 失调在阿尔茨海默病中的作用
- 批准号:
10739065 - 财政年份:2023
- 资助金额:
$ 32.19万 - 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
- 批准号:
9261605 - 财政年份:2013
- 资助金额:
$ 32.19万 - 项目类别:
Abnormal Mitochondrial Dynamics and Mitochondrial Dysfunction in Alzheimer's Dise
阿尔茨海默病中的线粒体动力学异常和线粒体功能障碍
- 批准号:
8829930 - 财政年份:2013
- 资助金额:
$ 32.19万 - 项目类别:
相似国自然基金
肠道菌群对溶瘤腺病毒免疫治疗的影响与机制及综合治疗策略的研究
- 批准号:82272819
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
肠道菌群对溶瘤腺病毒免疫治疗的影响与机制及综合治疗策略的研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
DENND2D的诱导表达对非小细胞肺癌细胞恶性表型影响及其作用机制研究
- 批准号:81802284
- 批准年份:2018
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清4型禽腺病毒3'端135-bp自然缺失影响病毒致病性的研究
- 批准号:31702268
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 32.19万 - 项目类别:
Mechanistic factors limiting utility of adenovirus vectors for treatment of neopla
限制腺病毒载体治疗肿瘤的机制因素
- 批准号:
10618174 - 财政年份:2022
- 资助金额:
$ 32.19万 - 项目类别:
Neural mechanisms preventing postpartum relapse to cocaine seeking in new mothers
防止新妈妈产后复发寻找可卡因的神经机制
- 批准号:
10354553 - 财政年份:2022
- 资助金额:
$ 32.19万 - 项目类别:
Neural mechanisms preventing postpartum relapse to cocaine seeking in new mothers
防止新妈妈产后复发寻找可卡因的神经机制
- 批准号:
10614372 - 财政年份:2022
- 资助金额:
$ 32.19万 - 项目类别:
Viral subversion of intercellular coupling during myocarditis
心肌炎期间细胞间耦合的病毒颠覆
- 批准号:
10522824 - 财政年份:2022
- 资助金额:
$ 32.19万 - 项目类别: